GRFS
Price:
$7.82
Market Cap:
$5.73B
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic ...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2011-06-02
Stock Exchange
NASDAQ
Ticker
GRFS
According to Grifols, S.A.’s latest financial reports and current stock price. The company's current ROE is 3.18%. This represents a change of 302.07% compared to the average of 0.79% of the last 4 quarters.
The mean historical ROE of Grifols, S.A. over the last ten years is 11.47%. The current 3.18% ROE has changed -72.27% with respect to the historical average. Over the past ten years (40 quarters), GRFS's ROE was at its highest in in the December 2017 quarter at 6.36%. The ROE was at its lowest in in the March 2023 quarter at -0.18%.
Average
11.47%
Median
13.54%
Minimum
1.02%
Maximum
18.26%
Discovering the peaks and valleys of Grifols, S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 24.59%
Maximum Annual ROE = 18.26%
Minimum Annual Increase = -70.04%
Minimum Annual ROE = 1.02%
Year | ROE | Change |
---|---|---|
2023 | 1.02% | -70.04% |
2022 | 3.40% | -21.93% |
2021 | 4.35% | -64.06% |
2020 | 12.11% | -6.60% |
2019 | 12.96% | -8.19% |
2018 | 14.12% | -22.68% |
2017 | 18.26% | 24.59% |
2016 | 14.66% | -9.21% |
2015 | 16.14% | -8.74% |
2014 | 17.69% | 7.58% |
The current ROE of Grifols, S.A. (GRFS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.92%
5-year avg
6.77%
10-year avg
11.47%
Grifols, S.A.’s ROE is less than Novartis AG (41.08%), less than AstraZeneca PLC (16.57%), less than GSK plc (18.08%), less than Roche Holding AG (36.46%), greater than Bristol-Myers Squibb Company (-36.26%), less than Merck & Co., Inc. (29.27%), less than Gilead Sciences, Inc. (0.65%), less than Amgen Inc. (68.49%), less than Biogen Inc. (10.38%), less than Sanofi (6.13%),
Company | ROE | Market cap |
---|---|---|
41.08% | $192.42B | |
16.57% | $205.57B | |
18.08% | $69.43B | |
36.46% | $225.56B | |
-36.26% | $117.15B | |
29.27% | $251.57B | |
0.65% | $117.09B | |
68.49% | $142.17B | |
10.38% | $21.72B | |
6.13% | $120.51B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Grifols, S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Grifols, S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Grifols, S.A.'s ROE?
How is the ROE calculated for Grifols, S.A. (GRFS)?
What is the highest ROE for Grifols, S.A. (GRFS)?
What is the 3-year average ROE for Grifols, S.A. (GRFS)?
What is the 5-year average ROE for Grifols, S.A. (GRFS)?
How does the current ROE for Grifols, S.A. (GRFS) compare to its historical average?